Serveur d'exploration Tocilizumab - Analysis (France)

Index « Titre (en) » - entrée « rheumatoid »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
rheumatism < rheumatoid < rheumatological  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 200.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2020) Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France]The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.
000014 (2020) Alexandre Sepriano [Oman] ; Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas]Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
000015 (2020) Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000026 (2020) François Santinon [France] ; Maxime Batignes [France] ; Majda Lyna Mebrek [France] ; Jerôme Biton [France] ; Gaëlle Clavel [France] ; Roxane Hervé [France] ; Delphine Lemeiter [France] ; Magali Breckler [France] ; Florence Busato [France] ; Jorg Tost [France] ; Marianne Ziol [France] ; Marie-Christophe Boissier [France] ; Patrice Decker [France] ; Luca Semerano [France] ; Natacha Bessis [France]Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
000032 (2020) Charlotte Hua [France] ; Frank Buttgereit [Allemagne] ; Bernard Combe [France]Glucocorticoids in rheumatoid arthritis: current status and future studies
000033 (2020) Jacqueline M. Tarrant [États-Unis] ; René Galien [France] ; Wanying Li [États-Unis] ; Lovely Goyal [États-Unis] ; Yang Pan [États-Unis] ; Rachael Hawtin [États-Unis] ; Wangshu Zhang [États-Unis] ; Annegret Van Der Aa [Belgique] ; Peter C. Taylor [Royaume-Uni]Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
000034 (2020) Gaëlle Vial [France] ; Anaïs De Pouilly [France] ; Laetitia Scouppe [France] ; Bruno Pereira [France] ; Claire Daien [France] ; Cédric Lukas [France] ; Adeline Ruyssen-Witrand [France] ; Pascale Vergne-Salle [France] ; Christophe Richez [France] ; Anne Tournadre [France]Factors influencing the choice of biologic therapy following Rituximab in patients with rheumatoid arthritis: A retrospective study using propensity score.
000035 (2020) Andreas Kerschbaumer [Autriche] ; Alexandre Sepriano [Pays-Bas] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas]Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
000038 (2020) Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis]Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France.
000040 (2020) Josef S. Smolen [Autriche] ; Robert B M. Landewé [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Andreas Kerschbaumer [Autriche] ; Iain B. Mcinnes [Royaume-Uni] ; Alexandre Sepriano [Pays-Bas] ; Ronald F. Van Vollenhoven [Pays-Bas] ; Maarten De Wit [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; John Askling [Suède] ; Alejandro Balsa [Espagne] ; Maarten Boers [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Maya H. Buch [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Roberto Caporali [Italie] ; Mario Humberto Cardiel [Mexique] ; Diederik De Cock [Belgique] ; Catalin Codreanu [Roumanie] ; Maurizio Cutolo [Italie] ; Christopher John Edwards [Royaume-Uni] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Royaume-Uni] ; Axel Finckh [Suisse] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Merete Lund Hetland [Danemark] ; Tom W J. Huizinga [Pays-Bas] ; Marios Koloumas [Suisse] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Ulf Müller-Ladner [Allemagne] ; Eduardo F. Mysler [Argentine] ; Jose A P. Da Silva [Portugal] ; Gyula Po R [Hongrie] ; Janet E. Pope [Canada] ; Andrea Rubbert-Roth [Suisse] ; Adeline Ruyssen-Witrand [France] ; Kenneth G. Saag [États-Unis] ; Anja Strangfeld [Allemagne] ; Tsutomu Takeuchi [Japon] ; Marieke Voshaar [Pays-Bas] ; René Westhovens [Belgique] ; Désirée Van Der Heijde [Pays-Bas]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
000042 (2020) Kassandra Lanchais ; Frederic Capel ; Anne Tournadre [France]Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
000043 (2020) Siddharth Singh ; Mathurin Fumery [France] ; Abha G. Singh ; Namrata Singh [États-Unis] ; Larry J. Prokop [États-Unis] ; Parambir S. Dulai ; William J. Sandborn ; Jeffrey R. CurtisComparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
000050 (2019-06-12) Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission
000052 (2019-06-12) Alain Saraux [France] ; Thomas Barnetche [France] ; Guy Baudens [France] ; Isabelle Idier [France] ; Flore Delaporte [France] ; Pascal Hilliquin [France]Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.
000059 (2019) Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France]Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
000068 (2019) Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000069 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
000070 (2019) Souraya Sayegh [France, Liban] ; Oula El Atat [Liban] ; Katy Diallo [France] ; Benjamin Rauwel [France] ; Yannick Degboé [France] ; Etienne Cavaignac [France] ; Arnaud Constantin [France] ; Alain Cantagrel [France] ; Viviane Trak-Smayra [Liban] ; Nada Alaaeddine [Liban] ; Jean-Luc Davignon [France]Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
000072 (2019) Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France]Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
000076 (2019) Yannick Degboé [France] ; Benjamin Rauwel [France] ; Michel Baron [France] ; Jean-Frédéric Boyer [France] ; Adeline Ruyssen-Witrand [France] ; Arnaud Constantin [France] ; Jean-Luc Davignon [France]Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
000083 (2019) Audrey Paoletti [France] ; Julien Rohmer [France] ; Bineta Ly [France] ; Juliette Pascaud [France] ; Elodie Rivière [France] ; Raphaele Seror [France] ; Benoit Le Goff [France] ; Gaetane Nocturne [France] ; Xavier Mariette [France]Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i -k "rheumatoid" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i  \
                -Sk "rheumatoid" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    rheumatoid
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021